AUG 28, 2018 10:37 PM PDT

Alternative Therapy for Peripheral Artery Disease

WRITTEN BY: Nouran Amin

Image Credit: conehealth.com

To fight peripheral artery diseases (PAD), an “ailment affecting 8 million Americans”, researchers at LSU School of Veterinary Medicine have discovered two drugs found in red wine that may serve as an alternative treatment: resveratrol and quercetin.

These particular drugs hold beneficial effects on arterial cells, such as healing, without any adverse side effects commonly seen in PAD therapies. The researcher’s goal was to use drugs that do not pose a threat to cells but rather restrict them from growing and narrowing an artery. "Dr. Dugas discovered that these two drugs in combination worked well for that purpose," said Crisitna Sabliov, LSU Biological and Agricultural Engineering professor. "She found the right potion, but she wanted the drugs released over time, and for that, she needed a smart delivery system. To be able to do that, Assistant Research Professor Carlos Astete and myself loaded these drugs into a nanoparticle," says Sabliov. "Nanoparticles are really, really small -- only 100-200 nanometers (nm). In comparison, a hair is 70,000 nm thick."

Researchers will seek to develop a drug-coated balloon (DCB) therapy where red wine compounds are sprayed evenly on the outside of a balloon in a nanoparticle can adhere to vessel walls, releasing the compound and preventing the growth of cells and narrowing of vessels to allow blood. "The whole procedure takes only a few minutes, so we need to make sure the particles are released from the balloon very quickly," said Sabliov.

However, research is never simple: "We have some challenges because, number one, you want the drugs released over time," Sabliov said. "And number two, the two different chemicals have to be in the optimum ratio that she [Dugas] finds works best. If they have a positive charge, then they attach quickly to the cells. "The ratio must be 1:2 because that's the magic potion that will make the drugs effective. We didn't want the drugs to kill the cells. We just wanted them to prevent the cells from growing back."

Learn more about peripheral artery disease (PAD):

Source: Louisiana State University, Journal of Biomedical Materials

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
JAN 21, 2021
Health & Medicine
Injectable Cannabis Overdose Drug Being Developed
JAN 21, 2021
Injectable Cannabis Overdose Drug Being Developed
It’s estimated that the number of visits to emergency rooms because of cannabis overdose tripled between 2011 and ...
JAN 20, 2021
Drug Discovery & Development
Designer Cytokine: Potential Therapeutic Approach for Paralysis
JAN 20, 2021
Designer Cytokine: Potential Therapeutic Approach for Paralysis
Paralysis due to spinal cord damage remains an irreparable condition. However, a new therapeutic approach may bring rene ...
FEB 26, 2021
Microbiology
Good Bacteria Fights Bad Bacteria in a Clinical Trial
FEB 26, 2021
Good Bacteria Fights Bad Bacteria in a Clinical Trial
Eczema is a skin condition that causes a chronic, itchy rash. The most common form of the disorder, atopic dermatitis, i ...
MAR 02, 2021
Immunology
Another Trick up Tumors' Sleeves Exposed
MAR 02, 2021
Another Trick up Tumors' Sleeves Exposed
Tumors have sneaky strategies for establishing themselves within healthy tissues, flourishing in plain sight of circulat ...
MAY 04, 2021
Health & Medicine
Micro-dosing Inhaler Breakthrough for Medical Cannabis
MAY 04, 2021
Micro-dosing Inhaler Breakthrough for Medical Cannabis
In a leap that will eliminate the risks of vaping or smoking, Canada has just approved an Israeli-made inhaler that is a ...
MAY 14, 2021
Health & Medicine
A National Standard THC Dose for Researchers is Here
MAY 14, 2021
A National Standard THC Dose for Researchers is Here
    Whatever your stance on cannabis, almost  everyone would agree that more, better quality, research sh ...
Loading Comments...